Skip to main content
. 2014 Feb 27;5(2):e1087. doi: 10.1038/cddis.2014.22

Table 3a. RT-PCR primer.

JunD
 5′-ATGGACACGCAGGAGCGCAT-3′(forward)
 5′-AGCAGCTGGCAGCCGCTGTT-3′(reverse)
 −210 bp product (expected amplified product)
 
CDC2
 5′-CCATACCATTGACTAACTATGGAAGAT-3′(forward)
 5′-GTCAGAAAGCTACATCTTCTTAATCTG-3′(reverse)
 −894 bp product (expected amplified product)
 
Cyclin B1
 5′-CCATTATTGATCGGTTCATGCAGA-3′(forward)
 5′-CTAGTGCAGAATTCAGCTGTGGTA-3′(reverse)
 −561 bp product (expected amplified product)
 
GADD45α
 5′-AGATCCACTTCACCCTG-3′(forward)
 5′-ACCGTTCAGGGAGATTA-3′(reverse)
 −267 bp product (expected amplified product)
 
GADD45β
 5′-GGCTCTCTGGCTCGGATTTT-3′(forward)
 5′-GATGTAGGGGACCCACTGGTT-3′(reverse)
 −522 bp product (expected amplified product)
 
GADD45γ
 5′-GTCTACGAGTCAGCCAAAGTC-3′(forward)
 5′-AAAGCCTGGATCAGCGTAAAAT-3′(reverse)
 −103 bp product (expected amplified product)
 
GAPDH
 5′-GTCTCCTCTGACTTCAACAGCG-3′ (forward)
 5′-ACCACCCTGTTGCTGTAGCCAA-3′ (reverse)
 −532 bp product (expected amplified product)